130 related articles for article (PubMed ID: 21485120)
1. [Comparison of four immunoassay screening devices for detection of benzodiazepine and its metabolites in urine: mainly detection of etizolam, thienodiazepine and its metabolites].
Namera A; Makita R; Nagao M
Chudoku Kenkyu; 2011 Mar; 24(1):27-34. PubMed ID: 21485120
[TBL] [Abstract][Full Text] [Related]
2. [Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine].
Torikoshi A; Namera A; Arima Y; Toubou H; Tajima T; Shiraishi H; Nagao M
Chudoku Kenkyu; 2014 Mar; 27(1):33-8. PubMed ID: 24724359
[TBL] [Abstract][Full Text] [Related]
3. Case report: Etizolam and its major metabolites in two unnatural death cases.
Nakamae T; Shinozuka T; Sasaki C; Ogamo A; Murakami-Hashimoto C; Irie W; Terada M; Nakamura S; Furukawa M; Kurihara K
Forensic Sci Int; 2008 Nov; 182(1-3):e1-6. PubMed ID: 18976871
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
Moriya F; Hashimoto Y
Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
[TBL] [Abstract][Full Text] [Related]
5. Urine levels of drugs for which Triage DOA screening was positive.
Moriya F
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S434-6. PubMed ID: 19261513
[TBL] [Abstract][Full Text] [Related]
6. Application of the Triage panel for drugs of abuse to forensic blood samples.
Moriya F; Hashimoto Y
Nihon Hoigaku Zasshi; 1996 Apr; 50(2):50-6. PubMed ID: 8691649
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of Triage for benzodiazepines: urine analysis of the dose of therapeutic cases.
Kurisaki E; Hayashida M; Nihira M; Ohno Y; Mashiko H; Okano T; Niwa S; Hiraiwa K
J Anal Toxicol; 2005 Sep; 29(6):539-43. PubMed ID: 16168176
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of triage as drug-of-abuse test kit].
Yoshioka T; Kohriyama K; Kondo R; Goto K; Yashiki M
Chudoku Kenkyu; 2003 Jan; 16(1):63-71. PubMed ID: 12712544
[TBL] [Abstract][Full Text] [Related]
9. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department.
von Mach MA; Weber C; Meyer MR; Weilemann LS; Maurer HH; Peters FT
Ther Drug Monit; 2007 Feb; 29(1):27-39. PubMed ID: 17304147
[TBL] [Abstract][Full Text] [Related]
10. ELISA Detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in Blood Using Immunalysis® Benzodiazepine Kit.
O'Connor LC; Torrance HJ; McKeown DA
J Anal Toxicol; 2016 Mar; 40(2):159-61. PubMed ID: 26518230
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the on-site immunoassay drug-screening device Triage-TOX in routine forensic autopsy.
Tominaga M; Michiue T; Maeda H
Leg Med (Tokyo); 2015 Nov; 17(6):499-502. PubMed ID: 26593997
[TBL] [Abstract][Full Text] [Related]
12. A Liquid-Chromatography High-Resolution Mass Spectrometry Method for Non-FDA Approved Benzodiazepines.
van Wijk XMR; Yun C; Hooshfar S; Arens AM; Lung D; Wu AHB; Lynch KL
J Anal Toxicol; 2019 May; 43(4):316-320. PubMed ID: 30462225
[TBL] [Abstract][Full Text] [Related]
13. Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases.
Hikin LJ; Smith PR; Maskell PD; Kurimbokus H; Ashong E; Couchman L; Morley SR
Med Sci Law; 2021 Apr; 61(2):122-129. PubMed ID: 33236683
[TBL] [Abstract][Full Text] [Related]
14. Accidental etizolam ingestion in a child.
Kato Z; Nakamura M; Funato M; Kuwabara H; Kondo N
Pediatr Emerg Care; 2007 Jul; 23(7):472-3. PubMed ID: 17666930
[TBL] [Abstract][Full Text] [Related]
15. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test.
Bertol E; Vaiano F; Borsotti M; Quercioli M; Mari F
J Anal Toxicol; 2013; 37(9):659-64. PubMed ID: 23943436
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of Triagetrade mark for Benzodiazepines: Urine Analysis of the Dose of Therapeutic Cases.
Kurisaki E; Hayashida M; Nihira M; Ohno Y; Mashiko H; Okano T; Niwa SI; Hiraiwa K
J Anal Toxicol; 2005; 29(6):539-543. PubMed ID: 16297284
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of four immunoassay screening kits for the detection of benzodiazepines in urine.
DeRienz RT; Holler JM; Manos ME; Jemionek J; Past MR
J Anal Toxicol; 2008; 32(6):433-7. PubMed ID: 18652750
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three commercial tests for buprenorphine screening in urine.
Leino A; Loo BM
Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of DRIVEN-FLOW® M7-II, a new on-site drug screening kit in postmortem urine compared with Triage DOA®.
Tanaka T; Yoshizumi S; Kasai K; Yoshida K; Sato H
Leg Med (Tokyo); 2021 Feb; 48():101804. PubMed ID: 33152676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
